Antiphospholipid syndrome: review.

Antiphospholipid syndrome spans many medical disciplines. Classic criteria include the presence of anticardiolipin antibody or lupus anticoagulant with typical complications of thrombosis or pregnancy loss. Other common associated manifestations include livedo reticularis, thrombocytopenia, valvular heart disease, and nephropathy with renal insufficiency, hypertension, and proteinuria. Treatment of serious complications with anticoagulation is standard; generally warfarin for thrombosis and aspirin/heparin for pregnancy prophylaxis. Detailed recommendations regarding precise intensity and duration of anticoagulation are still a subject of debate.

[1]  D. D'cruz,et al.  Renal manifestations of the antiphospholipid syndrome , 2005, Lupus.

[2]  R. Sacco,et al.  Antiphospholipid Antibodies and Risk for Recurrent Vascular Events—Reply , 2004 .

[3]  C. Mackworth-Young.  Antiphospholipid syndrome: multiple mechanisms , 2004, Clinical and experimental immunology.

[4]  G. Espinosa,et al.  Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies , 2004, Annals of the rheumatic diseases.

[5]  J. Merrill,et al.  LJP 1082: a toleragen for Hughes syndrome , 2004, Lupus.

[6]  R. Sacco,et al.  Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. , 2004, JAMA.

[7]  D. Mevorach,et al.  Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. , 2004, The Journal of thoracic and cardiovascular surgery.

[8]  P. Romagnoli,et al.  Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies , 2004, Lupus.

[9]  J. Salmon,et al.  The role of complement in the antiphospholipid syndrome. , 2004, Current directions in autoimmunity.

[10]  R. Roubey.  New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials, and tribulations. , 2003, Arthritis and rheumatism.

[11]  D. Damron.  Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. , 2003, Obstetrics and gynecology.

[12]  M. Galeazzi,et al.  HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. , 2003, Autoimmunity reviews.

[13]  J. Douketis,et al.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. , 2003, The New England journal of medicine.

[14]  Y. Shoenfeld,et al.  Atherosclerosis and antiphospholipid syndrome , 2003, Clinical reviews in allergy & immunology.

[15]  Y. Shoenfeld,et al.  Prophylaxis of the antiphospholipid syndrome: a consensus report , 2003, Lupus.

[16]  Y. Shoenfeld,et al.  Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines , 2003, Lupus.

[17]  J. Piette,et al.  Long term outcome of catastrophic antiphospholipid syndrome survivors , 2003, Annals of the rheumatic diseases.

[18]  H. Moutsopoulos,et al.  Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. , 2003, Arthritis and rheumatism.

[19]  J. Piette,et al.  Adrenal Involvement in the Antiphospholipid Syndrome: Clinical and Immunologic Characteristics of 86 Patients , 2003, Medicine.

[20]  L. Magder,et al.  Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. , 2002, The Journal of rheumatology.

[21]  A. Tincani,et al.  Pregnancy and neonatal outcome in primary antiphospholipid syndrome , 2002, Lupus.

[22]  J. Piette,et al.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. , 2002, Arthritis and rheumatism.

[23]  M. Lockshin,et al.  Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. , 2002, The Journal of rheumatology.

[24]  Xiaowei Liu,et al.  Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. , 2002, Arthritis and rheumatism.

[25]  R. Cimaz,et al.  Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations , 2002, Lupus.

[26]  M. Petri.  Management of thrombosis in antiphospholipid antibody syndrome. , 2001, Rheumatic diseases clinics of North America.

[27]  J. Buyon,et al.  High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. , 2001, Arthritis and rheumatism.

[28]  J. Nunemacher,et al.  Optimal management of giant cell arteritis and polymyalgia rheumatica , 2012, Therapeutics and clinical risk management.

[29]  M. Amigo,et al.  Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: Relationship to pathogenesis , 2000, Current rheumatology reports.

[30]  M. Khamashta,et al.  Can Neurologic Manifestations of Hughes (Antiphospholipid) Syndrome Be Distinguished from Multiple Sclerosis?: Analysis of 27 Patients and Review of the Literature , 2000, Medicine.

[31]  L. Sammaritano.  Drug-Induced Antiphospholipid Antibodies , 2000 .

[32]  D. D'cruz,et al.  Antiphospholipid Syndrome: General Features , 2000 .

[33]  Y. El‐Sayed,et al.  A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. , 2000, American journal of obstetrics and gynecology.

[34]  R. Silver,et al.  Anti–β2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome , 1999 .

[35]  F. Ohsuzu,et al.  Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. , 1999, The Journal of rheumatology.

[36]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[37]  J. Gris,et al.  Case-control Study of the Frequency of Thrombophilic Disorders in Couples with Late Foetal Loss and no Thrombotic Antecedent , 1999, Thrombosis and Haemostasis.

[38]  J. Chapman,et al.  Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes , 1999, Lupus.

[39]  R. Silver,et al.  Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. , 1999, American journal of obstetrics and gynecology.

[40]  J. Fish,et al.  Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies. , 1998, Clinical transplantation.

[41]  Y. Kanakura,et al.  High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant , 1998, American journal of hematology/oncology.

[42]  E. Svenungsson,et al.  Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. , 1998, The American journal of medicine.

[43]  G. Hughes,et al.  Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients , 1998, Lupus.

[44]  L. Berglund,et al.  Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[45]  J. Ilany,et al.  Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. , 1997, Seminars in arthritis and rheumatism.

[46]  M. Pittelkow,et al.  Antiphospholipid syndrome and the skin. , 1997, Journal of the American Academy of Dermatology.

[47]  Á. Chamorro,et al.  Chorea in the Antiphospholipid Syndrome: Clinical, Radiologic, and Immunologic Characteristics of 50 Patients from Our Clinics and the Recent Literature , 1997, Medicine.

[48]  R. Silver,et al.  Antiphospholipid Antibodies Other Than Lupus Anticoagulant and Anticardiolipin Antibodies in Women With Recurrent Pregnancy Loss, Fertile Controls, and Antiphospholipid Syndrome , 1997, Obstetrics and gynecology.

[49]  H. Cohen,et al.  Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) , 1997, BMJ.

[50]  A. Gori,et al.  Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus , 1996, Lupus.

[51]  W. Kutteh.  Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. , 1996, American journal of obstetrics and gynecology.

[52]  W. Kutteh,et al.  A Clinical Trial for the Treatment of Antiphospholipid Antibody‐Associated Recurrent Pregnancy Loss With Lower Dose Heparin and Aspirin , 1996, American journal of reproductive immunology.

[53]  M. Petri.  Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective. , 1996, Scandinavian journal of rheumatology.

[54]  J. Lasala,et al.  Activation of cultured vascular endothelial cells by antiphospholipid antibodies. , 1995, The Journal of clinical investigation.

[55]  Y. Berland,et al.  Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. , 1995, Kidney international.

[56]  L. Tenkanen,et al.  Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. , 1995, Circulation.

[57]  G. Hughes,et al.  Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. , 1993, The Journal of rheumatology.

[58]  R. Kaaja,et al.  Intravenous immunoglobulin treatment of Dregnant patients with recurrent pregnancy osses associated with antiphospholipid antibodies , 1993, Acta obstetricia et gynecologica Scandinavica.

[59]  M. Stampfer,et al.  Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis , 1992, Annals of Internal Medicine.

[60]  M. Amigo,et al.  Renal involvement in primary antiphospholipid syndrome. , 1992, The Journal of rheumatology.

[61]  D. Balaban,et al.  Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. , 1992, American journal of obstetrics and gynecology.

[62]  Y. Shoenfeld,et al.  The beta-2-glycoprotein I and antiphospholipid antibodies. , 1992, Clinical and experimental rheumatology.

[63]  J. Spinnato,et al.  Should anticardiolipin tests be performed in otherwise healthy pregnant women? , 1991, American journal of obstetrics and gynecology.

[64]  D. Sherman,et al.  Antiphospholipid antibodies and cerebral ischemia in young people , 1990, Neurology.

[65]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. Druzin,et al.  Antibody to cardiolipin, lupus anticoagulant, and fetal death. , 1987, The Journal of rheumatology.

[67]  G. Daggard,et al.  CORONARY ARTERY BYPASS GRAFT FAILURE—AN AUTOIMMUNE PHENOMENON? , 1986, The Lancet.

[68]  O. Vaarala,et al.  Anticardiolipin response in acute infections. , 1986, Clinical immunology and immunopathology.